イスラエルのバイオ医薬品研究市場

MicroMarketMonitorが発行した調査報告書(MMM5102010)
◆英語タイトル:Israel Bio-pharma Research Market [Product (Consumables-Assay, Kits and Reagent, Cell Line, Instrument {Separation, Imaging}, Software, Services)], [End User (Biotechnology/Biopharmaceutical Company/ CROs, Academic and Research institute)]- Forecast to 2020
◆商品コード:MMM5102010
◆発行会社(リサーチ会社):MicroMarketMonitor
◆発行日:2015年10月
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イスラエル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD2,650 ⇒換算¥299,450見積依頼/購入/質問フォーム
Multi User (Five User)USD3,250 ⇒換算¥367,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD4,505 ⇒換算¥509,065見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMicroMarketMonitor社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MicroMarketMonitor社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

The purpose of this report is to cover the definition, description, and forecast of the Israel bio-pharma research market. It involves a deep dive analysis of the market segmentation, which is based on products & services and end-user. The report also gives deep insights into the competitive landscape of the market through a strategic analysis of the key players of the market. On the basis of products and services, the Israel bio-pharma research market is segmented into instruments, consumables, bioreactors, services, and software. The consumables market is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to the increasing usage of consumables along with automation and advancements in detection technologies. However, the software market is expected to witness the highest growth during the forecast period, owing to the advancements in bioinformatics tools.

Israel bio-pharma research market is subsegmented into biotechnology/biopharmaceutical companies/CROs and academic and research institutes on basis of end users. The biotechnology/biopharmaceutical companies/CROs segment is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to factors such as the technological advancements, increased investments from governments and private companies.

The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals of the major companies have been detailed in the report. The main companies operating in this market are Thermo Fisher Scientific Inc. (U.S.), Merck KGAA (Germany), Perkinelmer Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson and Company (U.S.).

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 MARKET SCOPE 12
1.3.1 YEARS CONSIDERED FOR THE STUDY 12
1.4 CURRENCY 13
1.5 STAKEHOLDERS 13

2 RESEARCH METHODOLOGY 14
2.1 MARKET SIZE ESTIMATION 16
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 18
2.2.1 KEY DATA FROM SECONDARY SOURCES 19
2.2.2 KEY DATA FROM PRIMARY SOURCES 19
2.2.2.1 KEY INDUSTRY INSIGHTS 20
2.2.3 ASSUMPTIONS FOR THE STUDY 20

3 EXECUTIVE SUMMARY 21

4 PREMIUM INSIGHTS 24
4.1 ISRAEL BIO-PHARMA RESEARCH MARKET TO GROW AT A STEADY RATE 24
4.2 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES 24
4.3 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENTS AND CONSUMABLES 25
4.4 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENT 26
4.5 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER 26

5 MARKET OVERVIEW 27
5.1 INTRODUCTION 28
5.2 MARKET EVOLUTION 28
5.3 MARKET DYNAMICS 30
5.3.1 DRIVERS 31
5.3.1.1 RISING NUMBER OF PHARMACEUTICAL AND BIOTECH START-UPS 31
5.3.1.2 GOVERNMENT SUPPORT TO BOOST R&D ACTIVITIES 31
5.3.1.3 SUFFICIENT INVESTMENTS AND VENTURE CAPITAL FUNDS 32
5.3.1.4 AVAILABILITY OF SKILLED AND DIVERSE WORKFORCE 33
5.3.2 RESTRAINTS 34
5.3.3 OPPORTUNITIES 34
5.3.3.1 MERGERS & ACQUISITIONS 34
5.3.4 CURRENT TRENDS 35
5.3.4.1 ISRAELI BIOPHARMACEUTICAL COMPANIES INITIATING IPOS 35

6 INDUSTRY INSIGHTS 37
6.1 INTRODUCTION 37
6.2 MAJOR PRE-CLINICAL TRIALS OF BIOPHARMACEUTICAL PRODUCTS IN ISRAEL 38
6.3 ONGOING BIOPHARMACEUTICAL CLINICAL TRIALS IN ISRAEL 40
6.4 BUDGET/ PLANNED INVESTMENTS 50

7 ISRAEL HEALTHCARE SYSTEM 52
7.1 OVERVIEW 52
7.2 HISTORICAL DEVELOPMENT OF THE HEALTH SYSTEM IN ISRAEL 52
7.3 HEALTHCARE INDUSTRY IN ISRAEL 53
7.4 DISEASE BURDEN IN ISRAEL 54
7.5 HEALTHCARE EXPENDITURE IN ISRAEL 56
7.6 DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS 57
7.7 LEGAL REGULATORY FRAMEWORK OF CLINICAL TRIALS IN ISRAEL 58
7.7.1 LEGISLATION 58
7.7.2 REGULATORY AUTHORIZATION 58
7.7.3 DOCUMENTS REQUIRED 59
7.7.4 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE 60
7.8 ISRAEL: PHARMACEUTICAL IMPORT AND EXPORT 61

8 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES 65
8.1 INTRODUCTION 66
8.2 CONSUMABLES 67
8.2.1 INTRODUCTION 67
8.2.2 ASSAYS KITS AND REAGENTS 69
8.2.3 CELL CULTURE MEDIA 69
8.2.4 CELL LINES 70
8.2.5 MICROPLATES 70
8.2.6 OTHER CONSUMABLES 70
8.3 INSTRUMENTS 71
8.3.1 SEPARATION INSTRUMENTS 72
8.3.2 DETECTION AND SCREENING EQUIPMENT 73
8.3.3 IMAGING INSTRUMENTS 73
8.3.4 AUTOMATION AND HIGH-THROUGHPUT SCREENING INSTRUMENTS 74
8.3.5 OTHER INSTRUMENTS 74
8.4 BIOREACTORS 75
8.4.1 STAINLESS STEEL BIOREACTORS 76
8.4.2 SINGLE-USE BIOREACTORS 76
8.5 SOFTWARE 77
8.6 SERVICES 77

9 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER 78
9.1 INTRODUCTION 79
9.2 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS 80
9.3 ACADEMIC AND RESEARCH INSTITUTES 80

10 COMPANY PROFILES 81
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 AGILENT TECHNOLOGIES 82
10.2 BIO-RAD LABORATORIES, INC. 94
10.3 THERMO FISHER SCIENTIFIC, INC. 98
10.4 MERCK KGAA 104
10.5 PERKINELMER, INC. 108
10.6 SIGMA-ALDRICH CORPORATION 112
10.7 WATERS CORPORATION 120
10.8 SARTORIUS AG 126
10.9 BECTON, DICKINSON AND COMPANY 128
10.10 GENE BIO-APPLICATION LTD. 130
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

11 MARKET SHARE ANALYSIS 132

LIST OF TABLES

TABLE 1 RISING NUMBER OF PHARMACEUTICAL & BIOTECH START-UPS AND GOVERNMENT SUPPORT TO DRIVE THE ISRAEL BIO-PHARMA RESEARCH MARKET 33
TABLE 2 STRINGENT REGULATIONS FOR DRUG PRICING TO RESTRAIN THE ISRAEL
BIO-PHARMA RESEARCH MARKET GROWTH 34
TABLE 3 MERGERS AND ACQUISITIONS ARE PROVIDING SIGNIFICANT GROWTH OPPORTUNITIES FOR THE ISRAEL BIO-PHARMA RESEARCH MARKET 35
TABLE 4 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014 54
TABLE 5 ISRAEL: TOP DISEASES WITH HIGH MORTALITY RATES, 2012 54
TABLE 6 ISRAEL: NATIONAL EXPENDITURE ON HEALTH, BY TYPE OF SERVICE, OPERATING SECTOR, AND TYPE OF EXPENDITURE, 2012 56
TABLE 7 SUBMISSION PACKAGE REQUIRED FOR APPROVAL OF A CLINICAL STUDY IN ISRAEL 59
TABLE 8 ISRAEL: TOP IMPORTS, 2014 62
TABLE 9 ISRAEL: TOP EXPORTS, 2014 63
TABLE 10 LIST OF 17 MAJOR COMPANIES IN ISRAEL EXPORTING MEDICINE TO THE U.S., 2012 63
TABLE 11 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 66
TABLE 12 ISRAEL BIO-PHARMA RESEARCH CONSUMABLES MARKET SIZE, BY TYPE,
2013-–2020 (USD MILLION) 68
TABLE 13 ISRAEL BIO-PHARMA RESEARCH INSTRUMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 72
TABLE 14 ISRAEL BIO-PHARMA RESEARCH BIOREACTORS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 76
TABLE 15 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY END USER,
2013–2020 (USD MILLION) 79



LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 14
FIGURE 2 MARKET SIZE ESTIMATION 16
FIGURE 3 BREAK DOWN OF PRIMARY INTERVIEWS 17
FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 18
FIGURE 5 ISRAEL BIO-PHARMA RESEARCH MARKET SNAPSHOT (2015 VS. 2020) 21
FIGURE 6 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS AND SERVICES, 2015 22
FIGURE 7 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS SEGMENT WILL CONTINUE TO LEAD THE MARKET DURING THE FORECAST PERIOD 23
FIGURE 8 RISING NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY START-UPS AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH 24
FIGURE 9 SOFTWARE SEGMENT WILL BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 24
FIGURE 10 CONSUMABLES SEGMENT TO DOMINATE THE ISRAEL BIO-PHARMA RESEARCH MARKET IN 2015 25
FIGURE 11 IMAGING INSTRUMENTS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ISRAEL BIO-PHARMA RESEARCH IN 2015 26
FIGURE 12 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS SEGMENT TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020 26
FIGURE 13 EVOLUTION OF THE BIOPHARMACEUTICAL R&D SECTOR IN ISRAEL 29
FIGURE 14 ISRAEL BIO-PHARMA RESEARCH MARKET: DRIVERS, RESTRAINTS AND OPPORTUNITIES 30
FIGURE 15 ISRAEL: VENTURE CAPITAL FUNDING, LOCAL VS. FOREIGN, 2004–2013 32
FIGURE 16 DEVELOPMENTAL STAGES OF BIOPHARMACEUTICAL COMPANIES, 2014 37
FIGURE 17 CLINICAL TRIAL STAGE OF BIOPHARMACEUTICAL PRODUCTS IN 2015 38
FIGURE 18 CAPITAL RAISED BY ISRAELI LIFE SCIENCES COMPANIES, 2005-2017 (USD MILLION) 51
FIGURE 19 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014 53
FIGURE 20 ISRAEL: DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS 57
FIGURE 21 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE 60
FIGURE 22 ISRAEL: PHARMACEUTICAL IMPORTS ACCOUNTED FOR 2.6% OF THE TOTAL IMPORTS IN THE COUNTRY IN 2014 61
FIGURE 23 ISRAEL: PHARMACEUTICAL EXPORTS ACCOUNTED FOR 9.0% OF TOTAL EXPORTS
BY THE COUNTRY 62
FIGURE 24 CONSUMABLES TO FORM THE LARGEST SEGMENT OF THE ISRAEL BIO-PHARMA RESEARCH MARKET IN 2015 67
FIGURE 25 ASSAYS KITS AND REAGENTS IS EXPECTED TO DOMINATE THE CONSUMABLES MARKET IN 2015 68
FIGURE 26 IMAGING INSTRUMENTS TO COMMAND LARGEST SHARE OF THE ISRAEL
BIO-PHARMA RESEARCH INSTRUMENTS MARKET IN 2015 71
FIGURE 27 SINGLE-USE BIOREACTORS IS EXPECTED TO BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 75
FIGURE 28 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS, THE MAJOR END USERS OF THE ISRAEL BIO-PHARMA RESEARCH MARKET 79
FIGURE 29 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS 81
FIGURE 30 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 82
FIGURE 31 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 94
FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 98
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT 104
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT 108
FIGURE 35 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 112
FIGURE 36 WATERS CORPORATION: COMPANY SNAPSHOT 120
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT 126
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 128
FIGURE 39 ISRAEL BIO-PHARMA RESEARCH MARKET SHARE, BY KEY PLAYER, 2014 132




【レポートのキーワード】

バイオ医薬品、試薬、キット、装置、バイオ技術、医薬品、製薬、CRO、研究開発

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ イスラエルのバイオ医薬品研究市場(Israel Bio-pharma Research Market [Product (Consumables-Assay, Kits and Reagent, Cell Line, Instrument {Separation, Imaging}, Software, Services)], [End User (Biotechnology/Biopharmaceutical Company/ CROs, Academic and Research institute)]- Forecast to 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆